During the past decade, Beijing Obstetrics and Gynecology Hospital, Capital Medical University conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 3 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Obstetrics and Gynecology Hospital, Capital Medical University" #1 sponsor was "Beijing Obstetrics and Gynecology Hospital" with 5 trials, followed by "Capital Medical University" with 4 trials sponsored, "Bayer" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored and "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Obstetrics and Gynecology Hospital, Capital Medical University" #1 collaborator was "Beijing Obstetrics and Gynecology Hospital" with 2 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator, "Peking University First Hospital" with 2 trials as a collaborator, "Peking University Third Hospital" with 2 trials as a collaborator and "Beijing Anzhen Hospital" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Obstetrics and Gynecology Hospital, Capital Medical University" are "Intrauterine Adhesion" (5 trials), "Endometrial Neoplasms" (2 trials), "Endometriosis" (2 trials), "Gestational Diabetes Mellitus" (2 trials) and "Abortion, Spontaneous" (1 trials). Many other conditions were trialed in "Beijing Obstetrics and Gynecology Hospital, Capital Medical University" in a lesser frequency.

Most popular intervention types in "Beijing Obstetrics and Gynecology Hospital, Capital Medical University" are "Drug" (16 trials), "Device" (5 trials), "Procedure" (5 trials), "Behavioral" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "disposable balloon uterine stent" (4 trials), "dried biological amnion graft" (4 trials), "Carboplatin" (2 trials), "Lenvatinib" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Obstetrics and Gynecology Hospital, Capital Medical University" are 23 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Beijing Obstetrics and Gynecology Hospital, Capital Medical University". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Beijing Obstetrics and Gynecology Hospital, Capital Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Obstetrics and Gynecology Hospital, Capital Medical University, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".